Over the last 15-20 years, the UK has come to be seen by some in the global pharmaceutical industry as a problematic, low growth market which has erected many barriers to market access for new ...

A UK market access summit convened by IQVIA brought together pharma and NHS leaders to look at how working more closely – including more outcomes-based deals – could help UK life sciences ...

The UK risks losing £11 billion ($14 billion) in pharmaceutical R&D investment by 2033 unless urgent reforms are made to high ...

This report - Analyzing the Global Pharmaceutical Industry 2022 - presents a complete analysis of the global pharmaceutical industry by setting up an industry demarcation and providing a study on ...

DUBLIN--(BUSINESS WIRE)--The "Pharmaceutical Regulatory Affairs Market Size, Share & Trends Analysis Report By Service ... In addition, in the UK, the launch of The Accelerated Access ...

Dublin, May 16, 2025 (GLOBE NEWSWIRE) -- The "Pharmaceutical Drugs Industry ... and technological advances. The analysis includes recent developments in the product portfolios of major companies, as ...

The NHS Business Services Authority (NHSBSA) has published the annual Prescription Cost Analysis (PCA) for 2024/25.

According to an analysis from Reuters ... British Pharmaceutical Industry found 2,687 links between the UK pharmaceutical industry and academia in 2022, compared with 1,134 in 2003.

More information: Shai Mulinari et al, Patterns of company misconduct, recidivism, and complaint resolution delays: A temporal analysis of UK pharmaceutical industry self‐regulation within the ...

The U.K. government is proposing to raise the rebate rate under a national drug cost program, drawing complaints from the Association of the British Pharmaceutical Industry (ABPI). As one of the ...

Pharmaceutical market research analysis (PMRA) can validate a product's potential reach and market penetration capabilities. Investors use it to put a value on drug-making companies and their ...